Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Functional MRI detection of pharmacologically induced memory impairment.

Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert M.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):455-60. Epub 2001 Dec 26.

PMID:
11756667
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study.

Thiel CM, Henson RN, Dolan RJ.

Neuropsychopharmacology. 2002 Aug;27(2):282-92.

PMID:
12093602
[PubMed - indexed for MEDLINE]
Free Article
3.

Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.

Kamboj SK, Curran HV.

Psychopharmacology (Berl). 2006 Nov;188(4):482-8. Epub 2006 Sep 19.

PMID:
17047934
[PubMed - indexed for MEDLINE]
4.

Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.

Paulus MP, Feinstein JS, Castillo G, Simmons AN, Stein MB.

Arch Gen Psychiatry. 2005 Mar;62(3):282-8.

PMID:
15753241
[PubMed - indexed for MEDLINE]
5.

Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.

Mintzer MZ, Griffiths RR.

Cogn Affect Behav Neurosci. 2007 Jun;7(2):120-9.

PMID:
17672383
[PubMed - indexed for MEDLINE]
6.

Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.

Mintzer MZ, Griffiths RR.

Exp Clin Psychopharmacol. 2003 Feb;11(1):56-72.

PMID:
12622344
[PubMed - indexed for MEDLINE]
7.

Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze.

Antonova E, Parslow D, Brammer M, Simmons A, Williams S, Dawson GR, Morris R.

J Psychopharmacol. 2011 Sep;25(9):1256-65. doi: 10.1177/0269881110379285. Epub 2010 Sep 7.

PMID:
20823079
[PubMed - indexed for MEDLINE]
8.

Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention.

Gibbs RB, Burke AM, Johnson DA.

Horm Behav. 1998 Oct;34(2):112-25.

PMID:
9799622
[PubMed - indexed for MEDLINE]
9.

Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans.

Schon K, Atri A, Hasselmo ME, Tricarico MD, LoPresti ML, Stern CE.

J Neurosci. 2005 Oct 5;25(40):9112-23.

PMID:
16207870
[PubMed - indexed for MEDLINE]
Free Article
10.

Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia.

Menzies L, Ooi C, Kamath S, Suckling J, McKenna P, Fletcher P, Bullmore E, Stephenson C.

Arch Gen Psychiatry. 2007 Feb;64(2):156-67.

PMID:
17283283
[PubMed - indexed for MEDLINE]
11.

fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease.

Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS.

J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):44-50.

PMID:
12486265
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Caffeine attenuates scopolamine-induced memory impairment in humans.

Riedel W, Hogervorst E, Leboux R, Verhey F, van Praag H, Jolles J.

Psychopharmacology (Berl). 1995 Nov;122(2):158-68.

PMID:
8848531
[PubMed - indexed for MEDLINE]
13.

Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding.

Rosier AM, Cornette L, Dupont P, Bormans G, Mortelmans L, Orban GA.

Eur J Neurosci. 1999 Oct;11(10):3701-14.

PMID:
10564377
[PubMed - indexed for MEDLINE]
14.

Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.

Diamond EL, Miller S, Dickerson BC, Atri A, DePeau K, Fenstermacher E, Pihlajamäki M, Celone K, Salisbury S, Gregas M, Rentz D, Sperling RA.

Neurology. 2007 Sep 25;69(13):1331-41.

PMID:
17893294
[PubMed - indexed for MEDLINE]
15.

Left prefrontal cortex control of novel occurrences during recollection: a psychopharmacological study using scopolamine and event-related fMRI.

Bozzali M, MacPherson SE, Dolan RJ, Shallice T.

Neuroimage. 2006 Oct 15;33(1):286-95. Epub 2006 Aug 17.

PMID:
16919479
[PubMed - indexed for MEDLINE]
16.

Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study.

Rémy F, Mirrashed F, Campbell B, Richter W.

Neuroimage. 2005 Mar;25(1):253-66. Epub 2004 Dec 10.

PMID:
15734360
[PubMed - indexed for MEDLINE]
17.

The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.

Bahro M, Schreurs BG, Sunderland T, Molchan SE.

Psychopharmacology (Berl). 1995 Dec;122(4):395-400.

PMID:
8657840
[PubMed - indexed for MEDLINE]
18.

Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.

Petrella JR, Prince SE, Krishnan S, Husn H, Kelley L, Doraiswamy PM.

AJNR Am J Neuroradiol. 2009 Feb;30(2):411-6. doi: 10.3174/ajnr.A1359. Epub 2008 Nov 11.

PMID:
19001543
[PubMed - indexed for MEDLINE]
Free Article
19.

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.

Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.

J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30.

PMID:
19573495
[PubMed - indexed for MEDLINE]
20.

Evidence for a specific role of the anterior hippocampal region in successful associative encoding.

Chua EF, Schacter DL, Rand-Giovannetti E, Sperling RA.

Hippocampus. 2007;17(11):1071-80.

PMID:
17604351
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk